Shane McGann

Shane McGann, PharmD, RPh

Shane McGann, PharmD, RPh joined Mythic Therapeutics in January 2023 as Vice President of Regulatory Affairs, bringing with him over a decade of biopharmaceutical industry and leadership experience. Prior to Mythic, Shane spent time at BridgeBio and at Agios Pharmaceuticals, where he held positions of increasing responsibility and led global regulatory strategic planning and execution across Oncology and Rare Disease Portfolios, spanning all stages of clinical development In addition, while at Agios he was a Director and Preceptor for their Biopharmaceutical Industry Fellowship Program. Shane completed a post-doctoral Regulatory Affairs Fellowship at Genzyme, in conjunction with Massachusetts College of Pharmacy and Health Sciences where he was an adjunct faculty member. During his career, Shane has led, overseen, and/or supported the regulatory strategy for numerous preclinical and clinical drug development programs, including two approved targeted oncology therapies.

He is a licensed pharmacist and received his Doctor of Pharmacy from Albany College of Pharmacy and Health Sciences, where he is a Member of the Board of Trustees.